[Alzheimer disease. Pseudo-irreversible AChE inhibition with rivastigmine].
D000110:Acetylcholinesterase / Q000378:metabolism*; D000544:Alzheimer Disease / Q000188:drug therapy* / Q000201:enzymology; D001921:Brain / Q000201:enzymology; D002219:Carbamates / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D048448:Phenylcarbamates; D000068836:Rivastigmine
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D018696:Neuroprotective Agents; D048448:Phenylcarbamates; D000110:Acetylcholinesterase; D000068836:Rivastigmine
Alzheimer-Krankheit. Pseudo-irreversible AChE-Hemmung mit Rivastigmin.